Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women

被引:109
|
作者
Hamaguchi, Masahide [2 ]
Kojima, Takao [1 ]
Ohbora, Akihiro [1 ]
Takeda, Noriyuki [3 ]
Fukui, Michiaki [4 ]
Kato, Takahiro [1 ]
机构
[1] Asahi Univ, Dept Gastroenterol, Murakami Mem Hosp, Gifu 5008523, Japan
[2] Osaka Univ, Immunol Frontier Res Ctr, Osaka 5650871, Japan
[3] Asahi Univ, Dept Endocrinol & Metab, Murakami Mem Hosp, Gifu 5008523, Japan
[4] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kyoto 6028566, Japan
基金
日本学术振兴会;
关键词
Nonalcoholic fatty liver disease; Cardiovascular disease; Risk factor; Steatohepatitis; Postmenopausal women; METABOLIC SYNDROME; HEPATIC STEATOSIS; PREDICTOR; PREVALENCE; STEATOHEPATITIS; ASSOCIATION; NUTRITION;
D O I
10.3748/wjg.v18.i3.237
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To clarify the relationship between age, menopause, and nonalcoholic fatty liver disease (NAFLD) in women. METHODS: We conducted a follow-up study on nonalcoholic fatty liver disease by using abdominal ultrasonography, and investigated the relationship of age and menopause with the development of NAFLD in women. We followed 1829 women and 2572 men (response rate, 86%) selected in 2001 to represent the non-institutionalized adult population of Gifu, Japan. Data collected included self-reported medical history, lifestyle factors, and menopausal status. The postmenopausal state was defined as beginning 1 year after the cessation of menses. We diagnosed NAFLD with the aid of abdominal ultrasonography by using diagnostic criteria described previously. RESULTS: The prevalence of NAFLD in women increases with age, but does not alter with age in men. Furthermore, the prevalence of NAFLD in premenopausal women (6%) was lower than that in men (24%) and in postmenopausal women (15%). The associations of the postmenopausal state and hormone replacement therapy with NAFLD were statistically significant in a univariate logistic regression model. At the follow-up examination, 67 women (5%) were newly diagnosed with NAFLD. The incidence of NAFLD was 3.5% (28/802) in premenopausal women, 7.5% (4/53) in menopausal women, 6.1% (24/392) in postmenopausal women, and 5.3% (11/206) in women receiving hormone replacement therapy. The weight gain in premenopausal women was equal to that in postmenopausal women. Metabolic syndrome and weight gain were independent risk factors for NAFLD in pre- and postmenopausal women, but age was an independent risk factor in premenopausal women only. CONCLUSION: Aging is a risk factor for NAFLD in premenopausal women, independent of weight gain or influence of metabolic syndrome. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [1] Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women
    Masahide Hamaguchi
    Takao Kojima
    Akihiro Ohbora
    Noriyuki Takeda
    Michiaki Fukui
    Takahiro Kato
    [J]. World Journal of Gastroenterology, 2012, 18 (03) : 237 - 243
  • [2] Postmenopausal Women at Risk for Nonalcoholic Fatty Liver Disease
    Davidson, Robert
    [J]. US PHARMACIST, 2020, 45 (09) : 4 - 4
  • [3] Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
    Cho, Yoosun
    Chang, Yoosoo
    Choi, Hye Rin
    Kang, Jeonggyu
    Kwon, Ria
    Lim, Ga-Young
    Ahn, Jiin
    Kim, Kye-Hyun
    Kim, Hoon
    Hong, Yun Soo
    Zhao, Di
    Rampal, Sanjay
    Cho, Juhee
    Park, Hyun-Young
    Guallar, Eliseo
    Ryu, Seungho
    [J]. NUTRIENTS, 2022, 14 (14)
  • [4] Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease
    Vassilatou, E.
    Vassiliadi, D. A.
    Salambasis, K.
    Lazaridou, H.
    Koutsomitopoulos, N.
    Kelekis, N.
    Kassanos, D.
    Hadjidakis, D.
    Dimitriadis, G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (06) : 739 - 747
  • [5] Risk factors of nonalcoholic fatty liver disease in healthy women
    Guan, Hui
    Shao, Guangrui
    Cheng, Fang
    Ni, Pingjuan
    Wu, Mei
    [J]. MEDICINE, 2023, 102 (31) : E34437
  • [6] Is nonalcoholic fatty liver disease a risk factor for chronic kidney disease?
    Ozturk, Kadir
    Demirci, Hakan
    Kurt, Omer
    Kantarcioglu, Murat
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 608 - 609
  • [7] Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
    Carvalho, Kellyane Dias
    Daltro, Carla
    Rocha, Raquel
    Cotrim, Helma P.
    [J]. ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [8] Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
    Luo, Jun
    Xu, Li
    Li, Jiang
    Zhao, Shuiping
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (03) : 193 - 199
  • [9] Psoriasis or obesity is a risk factor for nonalcoholic fatty liver disease
    Rattanakaemakorn, Ploysyne
    Fleischer, Alan B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (03) : 588 - 588
  • [10] Nonalcoholic Fatty Liver Disease as a Risk Factor for Severe Cholangitis
    Mahamid, Mahmud
    Fteiha, Bashar
    Goldin, Eran
    Nseir, William
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (03): : 191 - 195